TegoScience Inc. (KOSDAQ:191420)

Market Cap	114.89B -13.0%
Revenue (ttm)	6.15B -11.2%
Net Income	-3.25B
EPS	-406.28
Shares Out	8.01M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,160
Average Volume	14,756
Open	14,470
Previous Close	n/a
Day's Range	14,010 - 14,470
52-Week Range	13,000 - 20,250
Beta	0.94
RSI	46.93
Earnings Date	Nov 14, 2025

About TegoScience

TegoScience Inc., a biotechnology-based cosmetics company, engages in the production of various skin cell therapy products originating from human epithelial cells in South Korea. The company offers Holoderm, a commercialized cultured skin autograft; Kaloderm, an allogeneic cell therapy product for healing wounds; Rosmir, a fibroblast cell therapy; and Neoderm, a three-dimensionally cultured skin model. It also provides KCM for skin regeneration effect; Chemotide, a single-chain human peptide; contract research services, such as biologics qualit...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2001
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 191420